Skip to content
value.today

CONTRAFECT Corp

🇺🇸 New York, New York, USABiotechnologyFounded 2008

Formerly ContraFect, Inc.

Total raised
$49 M
4 rounds on record
Latest round
$20 M
Jun 2015
First round on record
Aug 2010
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of CONTRAFECT Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$20 MNo. 4$10 to $50 million

CONTRAFECT Corp: Raise no. 4, Jun 2015

Investors in this round

9 investors had bought by the notice of Jun 25, 2015: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(c): may be advertised publicly; every buyer must be a verified accredited investor
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,200,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Julia P. Gregory · Executive Officer, Director
  • Michael C. Messinger · Executive Officer
  • Michael C. Wittekind, Ph.D. · Executive Officer
  • Natalie Yuan Bogdanos · Executive Officer
  • Cary C. Sucoff · Director
  • David C. Scheinberg, M.D., Ph.D. · Director
  • David N. Low, Jr. · Director
  • Isaac C. Blech · Director
  • Lawrence Yuan Tian, Ph.D. · Director
  • Michael J. Otto, Ph.D. · Director
  • Roger J. Pomerantz, Ph.D. · Director
  • Sol Barer, Ph.D. · Director
  • Steven C. Gilman, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Brookline Group, LLC (CRD 153587) · Birmingham, AlabamaSold in CT, IL, MA, NY, VT
  • M.M. Dillon & Co. LLC (CRD 19878) · Greenwich, ConnecticutSold in CT, NY

Signed by Julia P. Gregory, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 25, 2015. Read the notice at the SEC.

equity, optionsSEC
Jun 2013$12 MNo. 3$10 to $50 million

CONTRAFECT Corp: Raise no. 3, Jun 2013

Investors in this round

124 investors had bought by the notice of Sep 4, 2013: 124 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$12 M of $15 M offered; $3 M still to sell
Smallest investment taken
$25,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$1,500,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David P. Huang, M.D., Ph.D · Executive Officer
  • Julia P. Gregory · Executive Officer
  • Michael P. Wittekind, Ph.D. · Executive Officer
  • Robert Nowinski, Ph.D. · Executive Officer, Director
  • Cary Sucoff · Director
  • David Scheinberg, M.D., Ph.D. · Director
  • Issac Blech · Director
  • Shengda Zan · Director
  • Sir Richard Sykes, FRS · Director
  • Sol Barer, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states, and outside the US

Signed by Julia P. Gregory, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 4, 2013. Read the notice at the SEC.

debt, optionsSEC
Aug 2011$13 MNo. 2$10 to $50 million

CONTRAFECT Corp: Raise no. 2, Aug 2011

Investors in this round

125 investors had bought by the notice of Sep 15, 2011: 125 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $25 M offered; $13 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$875,203
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert C. Nowinski · Executive Officer, Director
  • Cary W. Sucoff · Director
  • David C. Scheinberg · Director
  • Isaac W. Blech · Director
  • Sol W. Barer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in AZ, CA, CO, CT, DE, FL, GA, IL, IN, KY, MA, MD, MI, MN, MO, NC, NJ, NV, NY, OH, PA, PR, RI, SC, TN, TX, VT, WA

Signed by Robert C. Nowinski, Chairman and Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 15, 2011. Read the notice at the SEC.

equitySEC
Aug 2010$4 MNo. 1$2 to $10 million

CONTRAFECT Corp: Raise no. 1, Aug 2010

Investors in this round

6 investors had bought by the notice of Aug 23, 2010: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $10 M offered; $6 M still to sell
Smallest investment taken
$100,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$389,340
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert C. Nowinski · Executive Officer
  • Cary W. Sucoff · Director
  • David C. Scheinberg · Director
  • John C. Abeles · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in AZ, CA, CO, CT, FL, IL, MA, MI, NJ, NV, NY, OH, PA, TN, TX, VT, WA, WI

Signed by Robert C. Nowinski, Chairman & Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 23, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • CONTRAFECT Corp chose not to state its revenue in its newest notice of a funding round (Jun 2015).

    SEC Form D · Jun 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2015

That is all the official record says: CONTRAFECT Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of CONTRAFECT Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 125 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by CONTRAFECT Corp
NameRoleNamed in
Julia P. GregoryExecutive officerJun 2015
Michael C. MessingerExecutive officerJun 2015
Michael C. Wittekind, Ph.D.Executive officerJun 2015
Natalie Yuan BogdanosExecutive officerJun 2015
David P. Huang, M.D., Ph.DExecutive officerSep 2013
Michael P. Wittekind, Ph.D.Executive officerSep 2013
Robert Nowinski, Ph.D.Executive officerSep 2013
Robert C. NowinskiExecutive officerSep 2011
Cary C. SucoffDirectorJun 2015
David C. Scheinberg, M.D., Ph.D.DirectorJun 2015
David N. Low, Jr.DirectorJun 2015
Isaac C. BlechDirectorJun 2015
Julia P. GregoryDirectorJun 2015
Lawrence Yuan Tian, Ph.D.DirectorJun 2015
Michael J. Otto, Ph.D.DirectorJun 2015
Roger J. Pomerantz, Ph.D.DirectorJun 2015
Sol Barer, Ph.D.DirectorJun 2015
Steven C. Gilman, Ph.D.DirectorJun 2015
Cary SucoffDirectorSep 2013
David Scheinberg, M.D., Ph.D.DirectorSep 2013
Issac BlechDirectorSep 2013
Robert Nowinski, Ph.D.DirectorSep 2013
Shengda ZanDirectorSep 2013
Sir Richard Sykes, FRSDirectorSep 2013
Cary W. SucoffDirectorSep 2011
David C. ScheinbergDirectorSep 2011
Isaac W. BlechDirectorSep 2011
Robert C. NowinskiDirectorSep 2011
Sol W. BarerDirectorSep 2011
John C. AbelesDirectorAug 2010